YT
Healthcare & Life Sciences
Yellow Jersey Therapeutics
Switzerland
Yellow Jersey Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, since acquired.
Acquiredacquired
acquired
Stage
About Yellow Jersey Therapeutics
Yellow Jersey Therapeutics is a startup based in Switzerland. Yellow Jersey Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences.
Yellow Jersey Therapeutics develops bi-specific antibodies for immune system modulation, including NM26, a clinical-stage treatment candidate for atopic dermatitis, and was acquired by Johnson & Johnson in 2024.
Explore Yellow Jersey Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.